EFFICACY OF LACTUCA SATIVA IN HYPERLIPIDEMIA: A PILOT STUDY

Siva Rami Reddy E Siva Rami Reddy E; Basavaraj S Adi Basavaraj S Adi; Arun Kumar Jamadade Arun Kumar Jamadade

Siva Rami Reddy E Faculty of Homoeopathy, Tantia University, Sri Ganganagar, Rajasthan.
Basavaraj S Adi Reader, Department of Pharmacy, Bharatesh Homoeopathic Medical College, Belagavi
Arun Kumar Jamadade Reader, Department of Anatomy, Bharatesh Homoeopathic Medical College, Belagavi

Abstract

Aim:Lactuca sativa has anti toxidant, anti inflammatory and anti diabetic activities. In the present pilot study is that efficacy of lactuca sativa in hyperlipidemia. Hyperlipidemia patients meeting the inclusion criteria were randomly assigned in to the treatment and placebo.

Methods: 40 all randomized patients in treatment group took lettuce seed capsule (1000 mg, once per day); whereas the patients in placebo group took placebo capsule (once per day) for 12 weeks. The lipid profile, blood pressure, body mass index and liver enzymes of the patients were evaluated at baseline, and after 6 and 12 weeks of the clinical trial.

Results: The final results showed that lactuca sativa capsules significantly p value 0.05 improved LDL, HDL, cholesterol, compared to the placebo group. It had no effect on systolic or diastolic blood pressure and the effect on BMI reduction was not significant (P>0.05) compared to placebo. The lettuce showed an inhibitory effect on atorvastatin-induced elevation of hepatic enzymes and possible liver toxicity. No serious side effect was reported for lettuce seed extract administration. Therefore, lettuce seed extract could be considered as a supplement for treatment of dyslipidemia.

Keywords: Pilot study, hyperlipidemia, lactuca sativa

Downloads

Download data is not yet available.

References

1. Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverses Cholesterol Transport. Ann Hepatol. 2017 Nov; 16(Suppl. 1: s3-105.):s27-s42.

2. Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s27-s42.

3. Ibrahim MA, Asuka E, Jialal I. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 17, 2020. Hypercholesterolemia.

4. Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, Wang DQ, Portincasa P. Bile Acid Physiology. Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s4-s14.

5. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984; 251:351–364.

6. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I. J Lipid Res. 2004; 45:1583–1593.

7. Yeagle PL. Modulation of membrane function by cholesterol. Biochimie. 1991 Oct; 73(10):1303-10.

8. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans. J Lipid Res. 2005; 46:179–190.

9. Zawacki AW, Dodge A, Woo KM, Ralphe JC, Peterson AL. In pediatric familial hypercholesterolemia, lipoprotein (a) is more predictive than LDL-C for early onset of cardiovascular disease in family members. J Clin Lipidol. 2018 Nov - Dec;12(6):1445-1451.

10. Dainis AM, Ashley EA. Cardiovascular Precision Medicine in the Genomics Era. JACC Basic Transl Sci. 2018 Apr; 3(2):313-326.

11. Postiglione A, Napoli C. Hyperlipidemia, and atherosclerosis cerebrovascular disease. Curr Opin Lipidol. 1995 Aug; 6(4):236–242.

12. Miller M. Is hypertrigliceridaemia an independent risk factor for coronary heart disease, The epidemiologic evidence. Eur Heart J. 1998 ;(Suppl H):H18–H22.

13. Jeppsen J, Hein HO, Suadicani P, Gyntelberg F. Triglyceride Concentracion and Ishemic Heart Disease. An Eight-year Follow-up in the Copenhagen Male Study, Circulation. 1998; 97:1209–1236.

14. Winterhalter-Jadrić M, Radovanović J, Jadrić R, Nakaš-Ićindić E, Radnić D, Mujić M. Budapest: 1997. Blood Level of Lactate dehydrogenase, creatine kinase and lactate in patients following post traumatic stress syndrome, Congress:Stress of Life. Abstract book: 24-25.

15. Coughlin SS. Post-traumatic Stress Disorder and Cardiovascular Disease. Open Cardiovasc Med J. 2011; 5:164–170.